AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 45 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $34,000 | -95.2% | 6,014 | -92.4% | 0.00% | -100.0% |
Q4 2020 | $707,000 | -34.1% | 79,120 | -14.1% | 0.00% | 0.0% |
Q3 2020 | $1,073,000 | -29.5% | 92,140 | -3.0% | 0.00% | -50.0% |
Q2 2020 | $1,522,000 | -62.1% | 94,950 | -85.8% | 0.00% | -33.3% |
Q1 2020 | $4,018,000 | +23.1% | 670,844 | +171.4% | 0.00% | -25.0% |
Q4 2019 | $3,263,000 | -10.7% | 247,187 | -16.0% | 0.00% | -20.0% |
Q3 2019 | $3,653,000 | +137.4% | 294,160 | +207.8% | 0.01% | +66.7% |
Q2 2019 | $1,539,000 | +15.8% | 95,560 | +126.3% | 0.00% | 0.0% |
Q1 2019 | $1,329,000 | -5.2% | 42,230 | -1.1% | 0.00% | -25.0% |
Q4 2018 | $1,402,000 | -40.9% | 42,700 | -45.7% | 0.00% | -20.0% |
Q3 2018 | $2,373,000 | -25.6% | 78,680 | -33.9% | 0.01% | -28.6% |
Q2 2018 | $3,189,000 | – | 119,020 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |